13
Views
29
CrossRef citations to date
0
Altmetric
Original Article

Role of N-Acetyltransferase Phenotype in Human Susceptibility To Bladder Carcinogenic Arylamines

, &
Pages 161-165 | Received 07 Jun 1979, Published online: 15 Feb 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Zongheng Zhu, Jinshan Zhang, Wei Jiang, Xianjue Zhang, Youkong Li & Xiaoming Xu. (2015) Risks on N-acetyltransferase 2 and bladder cancer: a meta-analysis. OncoTargets and Therapy 8, pages 3715-3720.
Read now
Klaus Golka, Thomas Reckwitz, Manuela Kempkes, Ingolf Cascorbi, Meinolf Blaszkewicz, Susanne E. Reich, Ivar Roots, Juergen Soekeland, Harald Schulze & Hermann M. Bolt. (1997) N-Acetyltransferase 2 (NAT2) and Glutathione S-Transferase μ (GSTM1) in Bladder-cancer Patients in a Highly Industrialized Area. International Journal of Occupational and Environmental Health 3:2, pages 105-110.
Read now
S. Mommsen & H. Wolf. (1985) N-Acetyltransferase Phenotypes in Bladder Tumour Patients with and without Carcinoma In situ in Selected Site Biopsies. Scandinavian Journal of Urology and Nephrology 19:3, pages 203-204.
Read now
E. J. Ariëns. (1984) Domestication of Chemistry by Design of Safer Chemicals: Structure-Activity Relationships. Drug Metabolism Reviews 15:3, pages 425-504.
Read now

Articles from other publishers (25)

J. Lewalter & P. Biedermann. 2002. The MAK‐Collection for Occupational Health and Safety. The MAK‐Collection for Occupational Health and Safety 67 105 .
J. Lewalter & P. Biedermann. 2002. The MAK-Collection for Occupational Health and Safety. The MAK-Collection for Occupational Health and Safety 1 21 .
Chih-Ming Lu, Meng-Chu Chung, Chung-Hsiung Huang & Ying-Chin Ko. (2005) Interaction Effect in Bladder Cancer between N-Acetyltransferase 2 Genotype and Alcohol Drinking. Urologia Internationalis 75:4, pages 360-364.
Crossref
Sarkar Mohamadi, Nseyo Unyime & Zhong Bao-Zhen. (2003) Effect of pH on mutagenicity of urine from smokers and nonsmokers. Environmental Toxicology and Pharmacology 13:1, pages 21-27.
Crossref
Klaus Golka, Verena Prior, Meinolf Blaszkewicz & Hermann M Bolt. (2002) The enhanced bladder cancer susceptibility of NAT2 slow acetylators towards aromatic amines: a review considering ethnic differences. Toxicology Letters 128:1-3, pages 229-241.
Crossref
Kenji Shibuta, Tsuyoshi Eto, Akemi Kataoka, Hiroshi Inoue, Hiroaki Ueo, Tomokazu Suzuki, Graham F. Barnard & Masaki Mori. (2001) Genetic polymorphism of N-acetyltransferase 2 in patients with esophageal cancer. The American Journal of Gastroenterology 96:12, pages 3419-3424.
Crossref
L.E. Johns & R.S. Houlston. (2000) N-acetyl transferase-2 and bladder cancer risk: A meta-analysis. Environmental and Molecular Mutagenesis 36:3, pages 221-227.
Crossref
Takahiko Katoh, Masahiro Nakano, Makoto Yoshioka, Hisato Inatomi, Tetsuro Matsumoto & Toshihiro Kawamoto. (2006) Urothelial Cancer Risk in Relation to Genotypes of Glutathione S‐Transferase ( GST ) M1, T1, P1 and N‐Acetyltransferase 2 ( NAT2 ), and Tobacco Smoking . Journal of Occupational Health 41:1, pages 12-18.
Crossref
N P Lang. (1997) Acetylation as an indicator of risk.. Environmental Health Perspectives 105:suppl 4, pages 763-766.
Crossref
LIDIA J. NOTARIANNI, P. DOBROCKY, G. GODLEWSKI, R. W. JONES & P. N. BENNETT. (2008) Caffeine as a metabolic probe: NAT2 phenotyping. British Journal of Clinical Pharmacology 41:3, pages 169-173.
Crossref
Edith Sim, Lesley A. Stanley, Angela Risch & Peter Thygesen. (1995) Xenogenetics in multifactorial disease susceptibility. Trends in Genetics 11:12, pages 509-512.
Crossref
T. Shirai, Y. Fradet, H. Huland, C. Bollack, M. Droller, R. Janknegt, P. Jones & S. Kagawa. (1995) THE ETIOLOGY OF BLADDER CANCER-ARE THERE ANY NEW CLUES OR PREDICTORS OF BEHAVIOR?. International Journal of Urology 2:s2, pages 64-75.
Crossref
Kenji Shibuta, Tadasu Nakashima, Masako Abe, Masami Mashimo, Masaki Mori, Hiroaki Ueo, Tsuyoshi Akiyoshi, Keizo Sugimachi & Tomokazu Suzuki. (1994) Molecular genotyping for N-acetylation polymorphism in Japanese patients with colorectal cancer. Cancer 74:12, pages 3108-3112.
Crossref
D. E. Neal. 1994. Tumours in Urology. Tumours in Urology 3 18 .
Rebecca Johnson Irvin & John G. Kuhn. (2016) The Role of Pharmacogenetics in Cancer Chemotherapy and the Development of Malignancy. Journal of Pharmacy Practice 6:1, pages 17-33.
Crossref
Y.W. Francis Lam & Milton V. Marshall. (2016) Genetically Determined Polymorphisms in Drug Metabolism. Journal of Pharmacy Practice 5:6, pages 317-336.
Crossref
P. Del Santo, G. Moneti, M. Salvadori, C. Saltutti, A. Delle Rose & P. Dolara. (1991) Levels of the adducts of 4-aminobiphenyl to hemoglobin in control subjects and bladder carcinoma patients. Cancer Letters 60:3, pages 245-251.
Crossref
Jeffrey R. Idle. (1991) Is environmental carcinogenesis modulated by host polymorphism?. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 247:2, pages 259-266.
Crossref
G. PONS, E. REY, O. CARRIER, M.O. RICHARD, C. MORAN, J. BADOUAL & G. OLIVE. (2009) MATURATION OF AFMU EXCRETION IN INFANTS. Fundamental & Clinical Pharmacology 3:6, pages 589-595.
Crossref
Y. Horai, K. Fujita & T. Ishizaki. (1989) Genetically determined N-acetylation and oxidation capacities in Japanese patients with non-occupational urinary bladder cancer. European Journal of Clinical Pharmacology 37:6, pages 581-587.
Crossref
P. DOLARA, M. LODOVICI, M. SALVADORI, C. SALTUTTI, A. DELLE ROSE, C. SELLI & D. KRIEBEL. (2008) Variations of Cortisol Hydroxylation and Paracetamol Metabolism in Patients with Bladder Carcinoma. British Journal of Urology 62:5, pages 419-426.
Crossref
A.E. Karakaya, I. Cok, S. Sardas, O. Gögüs & O.S. Sardas. (2016) N-Acetyltransferase Phenotype of Patients with Bladder Cancer. Human Toxicology 5:5, pages 333-335.
Crossref
DM Grant, BK Tang & W Kalow. (2012) A simple test for acetylator phenotype using caffeine.. British Journal of Clinical Pharmacology 17:4, pages 459-464.
Crossref
S Mommsen, A Sell & N Barfod. (1982) N-ACETYLTRANSFERASE PHENOTYPES OF BLADDER CANCER PATIENTS IN A LOW-RISK POPULATION. The Lancet 320:8309, pages 1228.
Crossref
RaymondA. Cartwright, HowardJ. Rogers, Denise Barham-Hall, RobinW. Glashan, RaadA. Ahmad, Elizabeth Higgins & MohidA. Kahn. (1982) ROLE OF N-ACETYLTRANSFERASE PHENOTYPES IN BLADDER CARCINOGENESIS: A PHARMACOGENETIC EPIDEMIOLOGICAL APPROACH TO BLADDER CANCER. The Lancet 320:8303, pages 842-846.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.